Search research articles
Contact Us
Filters
Showing results (71-80 of 83) with videos related to
Page
of 9
Sort By:
Biorxiv : the Preprint Server for Biology
|
November 14, 2023
Preventing NK cell activation in the damaged liver induced by cabozantinib/PD-1 blockade increases survival in hepatocellular carcinoma models
Satoru Morita, Hiroto Kikuchi, Grace Birch, et al.
Langenbeck'S Archives of Surgery
|
January 26, 2022
Outcomes of laparoscopic total gastrectomy in elderly patients: a propensity score matching analysis
Yuma Ebihara, Yo Kurashima, Yusuke Watanabe, et al.
Hepatology (Baltimore, Md.)
|
August 6, 2019
Dual Programmed Death Receptor-1 and Vascular Endothelial Growth Factor Receptor-2 Blockade Promotes Vascular Normalization and Enhances Antitumor Immune Responses in Hepatocellular Carcinoma
Kohei Shigeta, Meenal Datta, Tai Hato, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
December 14, 2021
Targeted amplicon sequencing for primary tumors and matched lymph node metastases in patients with extrahepatic cholangiocarcinoma
Toru Yamada, Yoshitsugu Nakanishi, Hideyuki Hayashi, et al.
Nature Communications
|
December 8, 2025
Inhibiting B cells enhances the efficacy of STING agonism or immune checkpoint blockade in hepatocellular carcinoma
Xin Liu, Zelong Liu, Chengzhan Zhu, et al.
Annals of Surgical Oncology
|
December 5, 2023
Impact of Neutrophil Extracellular Traps Identified by Citrullinated Histone H3 Immunohistochemistry for Postoperative Prognosis in Patients with Extrahepatic Cholangiocarcinomas
Hiroyuki Yamamoto, Yoshitsugu Nakanishi, Tomoko Mitsuhashi, et al.
Annals of Surgical Oncology
|
April 11, 2022
Predictors of Long-Term Survival in Pancreatic Ductal Adenocarcinoma after Pancreatectomy: TP53 and SMAD4 Mutation Scoring in Combination with CA19-9
Masato Ono, Yusuke Ono, Toru Nakamura, et al.
Biorxiv : the Preprint Server for Biology
|
February 7, 2023
Reprogramming Intrahepatic Cholangiocarcinoma Immune Microenvironment by Chemotherapy and CTLA-4 Blockade Enhances Anti-PD1 Therapy
Jiang Chen, Zohreh Amoozgar, Xin Liu, et al.
Journal for Immunotherapy of Cancer
|
November 25, 2020
Regorafenib combined with PD1 blockade increases CD8 T-cell infiltration by inducing CXCL10 expression in hepatocellular carcinoma
Kohei Shigeta, Aya Matsui, Hiroto Kikuchi, et al.
Cancer Immunology Research
|
January 23, 2024
Reprogramming the Intrahepatic Cholangiocarcinoma Immune Microenvironment by Chemotherapy and CTLA-4 Blockade Enhances Anti-PD-1 Therapy
Jiang Chen, Zohreh Amoozgar, Xin Liu, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 83) with videos related to
Sort By:
Page
of 9
Biorxiv : the Preprint Server for Biology
|
November 14, 2023
Preventing NK cell activation in the damaged liver induced by cabozantinib/PD-1 blockade increases survival in hepatocellular carcinoma models
Satoru Morita, Hiroto Kikuchi, Grace Birch, et al.
Langenbeck'S Archives of Surgery
|
January 26, 2022
Outcomes of laparoscopic total gastrectomy in elderly patients: a propensity score matching analysis
Yuma Ebihara, Yo Kurashima, Yusuke Watanabe, et al.
Hepatology (Baltimore, Md.)
|
August 6, 2019
Dual Programmed Death Receptor-1 and Vascular Endothelial Growth Factor Receptor-2 Blockade Promotes Vascular Normalization and Enhances Antitumor Immune Responses in Hepatocellular Carcinoma
Kohei Shigeta, Meenal Datta, Tai Hato, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association
|
December 14, 2021
Targeted amplicon sequencing for primary tumors and matched lymph node metastases in patients with extrahepatic cholangiocarcinoma
Toru Yamada, Yoshitsugu Nakanishi, Hideyuki Hayashi, et al.
Nature Communications
|
December 8, 2025
Inhibiting B cells enhances the efficacy of STING agonism or immune checkpoint blockade in hepatocellular carcinoma
Xin Liu, Zelong Liu, Chengzhan Zhu, et al.
Annals of Surgical Oncology
|
December 5, 2023
Impact of Neutrophil Extracellular Traps Identified by Citrullinated Histone H3 Immunohistochemistry for Postoperative Prognosis in Patients with Extrahepatic Cholangiocarcinomas
Hiroyuki Yamamoto, Yoshitsugu Nakanishi, Tomoko Mitsuhashi, et al.
Annals of Surgical Oncology
|
April 11, 2022
Predictors of Long-Term Survival in Pancreatic Ductal Adenocarcinoma after Pancreatectomy: TP53 and SMAD4 Mutation Scoring in Combination with CA19-9
Masato Ono, Yusuke Ono, Toru Nakamura, et al.
Biorxiv : the Preprint Server for Biology
|
February 7, 2023
Reprogramming Intrahepatic Cholangiocarcinoma Immune Microenvironment by Chemotherapy and CTLA-4 Blockade Enhances Anti-PD1 Therapy
Jiang Chen, Zohreh Amoozgar, Xin Liu, et al.
Journal for Immunotherapy of Cancer
|
November 25, 2020
Regorafenib combined with PD1 blockade increases CD8 T-cell infiltration by inducing CXCL10 expression in hepatocellular carcinoma
Kohei Shigeta, Aya Matsui, Hiroto Kikuchi, et al.
Cancer Immunology Research
|
January 23, 2024
Reprogramming the Intrahepatic Cholangiocarcinoma Immune Microenvironment by Chemotherapy and CTLA-4 Blockade Enhances Anti-PD-1 Therapy
Jiang Chen, Zohreh Amoozgar, Xin Liu, et al.
Page
of 9